<DOC>
	<DOCNO>NCT00003329</DOCNO>
	<brief_summary>RATIONALE : Identification gene may associate develop certain type cancer may someday provide important information person 's risk get cancer . PURPOSE : This clinical trial study see certain gene may associate cancer patient cancer breast , prostate , lung , colon sibling patient .</brief_summary>
	<brief_title>Identification Genes Associated With Cancer Patients Siblings Who Have Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Gather allele-sharing statistic approximately 100 candidate locus throughout human genome likely influence genetic risk cancer . - Use allele-sharing statistic test interaction locus individually cancer-associated , rare allele HRAS1 . - Generalize approach one four cancer ( breast , colon , lung , prostate ) , use allele-sharing statistic test interaction locus every locus . - Replicate positive result distinct set sibling pairs cancer . - Examine , locus contribute risk detect , influence genetic background clinical outcome , survival . OUTLINE : Each patient-sibling pair completes family history questionnaire incidence cancer family . Blood sample obtain patient sibling ( live parent , available ) . The blood sample genotyped use approximately 300 micro-satellite marker flank 100 candidate gene previously implicate genetic risk cancer . Certain loci priority due association HRAS1 : BRCA1 know mismatch repair locus ; repair gene , ATM ; Bloom 's syndrome locus ; XRCC group . Other gene also map . Patients receive result genetic test result influence type duration treatment . Patients follow annually . PROJECTED ACCRUAL : This study accrue 1,000 patient-sibling pair breast cancer . After 18 month , another 1,000 patient-sibling pair accrue breast cancer . Therefore , 2,000 patient-sibling pair accrue 5 year . ( Feasibility accrue pair lung , colon , prostate cancer assess . )</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colon , lung , prostate , invasive breast cancer No ductal lobular carcinoma situ breast Patient natural full sibling must ( ) cancer type Participants E3Y92 eligible Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Not specify Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage III non-small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>